Sigma Planning Corp’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.68M Buy
42,420
+54
+0.1% +$5.17K 0.1% 211
2025
Q4
$4.07M Sell
42,366
-796
-2% -$77.3K 0.11% 187
2025
Q3
$4.11M Sell
43,162
-900
-2% -$82.7K 0.12% 177
2025
Q2
$3.84M Buy
44,062
+766
+2% +$65K 0.12% 182
2025
Q1
$3.89M Buy
43,296
+3,404
+9% +$305K 0.12% 175
2024
Q4
$3.19M Buy
39,892
+11,049
+38% +$956K 0.1% 199
2024
Q3
$2.6M Buy
28,843
+124
+0.4% +$10.4K 0.08% 237
2024
Q2
$2.26M Buy
28,719
+3,838
+15% +$315K 0.07% 258
2024
Q1
$2.17M Buy
24,881
+13,387
+116% +$1.14M 0.07% 287
2023
Q4
$947K Sell
11,494
-22,416
-66% -$1.71M 0.07% 278
2023
Q3
$2.66M Sell
33,910
-468
-1% -$39.2K 0.1% 213
2023
Q2
$3.03M Sell
34,378
-3,992
-10% -$344K 0.11% 199
2023
Q1
$3.09M Buy
38,370
+15,614
+69% +$1.27M 0.1% 209
2022
Q4
$1.77M Sell
22,756
-1,936
-8% -$157K 0.06% 310
2022
Q3
$1.99M Buy
24,692
+2,168
+10% +$195K 0.08% 258
2022
Q2
$2.02M Sell
22,524
-1,659
-7% -$168K 0.07% 276
2022
Q1
$2.68M Buy
24,183
+2,992
+14% +$316K 0.08% 248
2021
Q4
$2.19M Buy
21,191
+1,226
+6% +$142K 0.06% 308
2021
Q3
$2.5M Sell
19,965
-251
-1% -$32.5K 0.08% 277
2021
Q2
$2.51M Sell
20,216
-3,382
-14% -$425K 0.07% 282
2021
Q1
$2.79M Buy
23,598
+1,911
+9% +$224K 0.09% 249
2020
Q4
$2.54M Sell
21,687
-3,488
-14% -$384K 0.09% 230
2020
Q3
$2.62M Buy
25,175
+58
+0.2% +$5.83K 0.1% 208
2020
Q2
$2.3M Sell
25,117
-2,826
-10% -$271K 0.1% 213
2020
Q1
$2.52M Buy
27,943
+6,685
+31% +$711K 0.15% 147
2019
Q4
$2.41M Buy
21,258
+4,260
+25% +$467K 0.1% 206
2019
Q3
$1.85M Buy
16,998
+2,854
+20% +$298K 0.09% 241
2019
Q2
$1.38M Sell
14,144
-51
-0.4% -$4.66K 0.07% 279
2019
Q1
$1.29M Buy
14,195
+1,447
+11% +$130K 0.07% 265
2018
Q4
$1.16M Buy
12,748
+387
+3% +$36.2K 0.08% 232
2018
Q3
$1.22M Buy
12,361
+852
+7% +$78.8K 0.07% 262
2018
Q2
$985K Sell
11,509
-273
-2% -$22.8K 0.07% 288
2018
Q1
$945K Buy
11,782
+813
+7% +$67.1K 0.07% 272
2017
Q4
$886K Buy
10,969
+486
+5% +$38.9K 0.07% 283
2017
Q3
$815K Sell
10,483
-36
-0.3% -$2.99K 0.07% 297
2017
Q2
$934K Sell
10,519
-1,872
-15% -$158K 0.09% 252
2017
Q1
$998K Sell
12,391
-865
-7% -$67.6K 0.1% 238
2016
Q4
$944K Sell
13,256
-5,254
-28% -$413K 0.1% 221
2016
Q3
$1.6M Buy
18,510
+386
+2% +$33.6K 0.19% 126
2016
Q2
$1.57M Sell
18,124
-1,009
-5% -$81.6K 0.21% 115
2016
Q1
$1.44M Buy
19,133
+2,597
+16% +$196K 0.2% 119
2015
Q4
$1.27M Sell
16,536
-1,098
-6% -$82.7K 0.18% 134
2015
Q3
$1.18M Sell
17,634
-1,174
-6% -$86.5K 0.19% 130
2015
Q2
$1.39M Sell
18,808
-8,903
-32% -$680K 0.19% 136
2015
Q1
$2.16M Buy
27,711
+9,549
+53% +$724K 0.29% 81
2014
Q4
$1.31M Buy
+18,162
New +$1.26M 0.17% 142

Other funds holding MDT

Sigma Planning Corp's MDT Position: Q1 2026 in Review

Sigma Planning Corp increased its Medtronic (MDT) stake by 0.13% in Q1 2026, buying an estimated $5.17K and bringing the position to 42,420 shares worth $3.68M. The position accounts for 0.1% of the portfolio, ranked #211.

Sigma Planning Corp first reported a position in MDT in Q4 2014 and has held it in 46 quarters since. The position peaked at $4.11M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Sigma Planning Corp held 42,420 shares of Medtronic worth $3.68M as of Q1 2026.
  • Sigma Planning Corp bought 54 Medtronic shares in Q1 2026, an estimated $5.17K.
  • Medtronic made up 0.1% of Sigma Planning Corp's portfolio in Q1 2026, its #211 holding.
  • Sigma Planning Corp first reported a position in Medtronic in Q4 2014 and has held it in 46 quarters since.
  • Sigma Planning Corp's Medtronic position peaked at $4.11M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.